These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22919757)

  • 1. [Different dosages Ganciclovir treatment of symptomatic congenital cytomegalovirus infection in neonatal].
    Hong-Bin Z; Feng-Xian Z; Cai-Ping G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):57-9. PubMed ID: 22919757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection].
    He XR; Chen PY; Wang T; Xie ZD; Hu JT; Bo T; Ge JF
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):641-4. PubMed ID: 19695189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of children with congenital cytomegalovirus infection with ganciclovir.
    Michaels MG; Greenberg DP; Sabo DL; Wald ER
    Pediatr Infect Dis J; 2003 Jun; 22(6):504-9. PubMed ID: 12799506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir therapy for congenital cytomegalovirus infection in six infants.
    Tanaka-Kitajima N; Sugaya N; Futatani T; Kanegane H; Suzuki C; Oshiro M; Hayakawa M; Futamura M; Morishima T; Kimura H
    Pediatr Infect Dis J; 2005 Sep; 24(9):782-5. PubMed ID: 16148844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir.
    Meine Jansen CF; Toet MC; Rademaker CM; Ververs TF; Gerards LJ; van Loon AM
    J Perinat Med; 2005; 33(4):364-6. PubMed ID: 16211780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ganciclovir treatment of congenital cytomegalovirus infection].
    Till A; Rózsai B; Kovács N; Storcz J; Somogyvári F; Deák J; Ertl T; Decsi T
    Orv Hetil; 2006 Apr; 147(13):609-12. PubMed ID: 16623443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.
    Müller A; Eis-Hübinger AM; Brandhorst G; Heep A; Bartmann P; Franz AR
    J Perinatol; 2008 Jan; 28(1):74-6. PubMed ID: 18165832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
    Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ganciclovir therapy for congenital cytomegalovirus infection in newborn infants: a meta analysis].
    Hu JT; Chen PY; Xie ZD; Dang XQ; Wang T; He XR; Li W; Bo T
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):35-9. PubMed ID: 20113632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.
    Bradford RD; Cloud G; Lakeman AD; Boppana S; Kimberlin DW; Jacobs R; Demmler G; Sanchez P; Britt W; Soong SJ; Whitley RJ;
    J Infect Dis; 2005 Jan; 191(2):227-33. PubMed ID: 15609232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital Cytomegalovirus Pneumonitis and Treatment Response Evaluation Using Viral Load during Ganciclovir Therapy: a Case Report.
    Lee-Yoshimoto M; Goishi K; Torii Y; Ito Y; Ono H; Mori T; Kashiwa N; Hosokawa S; Shichino H
    Jpn J Infect Dis; 2018 Jul; 71(4):309-311. PubMed ID: 29709989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged treatment with valganciclovir in an infant with congenital cytomegalovirus infection].
    Baquero-Artigao F; Romero Gómez MP
    An Pediatr (Barc); 2009 Jun; 70(6):578-81. PubMed ID: 19423406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients.
    Lee SO; Rim JH; Sung H; Kim SH; Choi SH; Lee CW; Yun TJ; Lee JW; Woo JH; Kim YS; Kim JJ
    Transpl Infect Dis; 2010 Feb; 12(1):31-7. PubMed ID: 19843292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
    Grzywacz M; Deayton JR; Bowen EF; Wilson P; Emery VC; Johnson MA; Griffiths PD
    J Med Virol; 1999 Nov; 59(3):323-8. PubMed ID: 10502264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
    Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study.
    Park SY; Lee SO; Choi SH; Kim YS; Woo JH; Baek S; Sung H; Kim MN; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    J Antimicrob Chemother; 2012 Jun; 67(6):1486-92. PubMed ID: 22354954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
    Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC
    Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.